We are live on
!
Find out more
SCM
Silverarc Capital Management Portfolio holdings
AUM
$849M
1-Year Est. Return
470.8%
This Fund
S&P 500
This Quarter
Est. Return
+56.43%
1 Year Est. Return
+470.8%
3 Year Est. Return
+3,352.06%
5 Year Est. Return
+7,957.7%
10 Year Est. Return
–
AUM
$164M
AUM Growth
–
Cap. Flow
+$143M
Cap. Flow
% of AUM
87.32%
Top 10 Holdings %
Top 10 Hldgs %
34.32%
Holding
81
New
81
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Vericel Corp
VCEL
|
+$6.7M |
| 2 |
Insmed
INSM
|
+$6.39M |
| 3 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$5.26M |
| 4 |
AMYT
Amryt Pharma plc American Depositary Shares
AMYT
|
+$5.25M |
| 5 |
DRNA
Dicerna Pharmaceuticals, Inc.
DRNA
|
+$5.01M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 92.29% |
| 2 | Financials | 0.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Vericel Corp
VCEL
$2.4B
| $8.69M | 5.3% |
+281,346
| New | +$6.7M |
|
|
ITCI
2
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $6.36M | 3.88% |
+200,000
| New | +$5.26M |
|
3
Delcath Systems
DCTH
$446M
| $6.3M | 3.85% |
+351,616
| New | +$4.82M |
|
|
4
Insmed
INSM
$23.6B
| $5.83M | 3.56% |
+175,000
| New | +$6.39M |
|
|
AMYT
5
DELISTED
Amryt Pharma plc American Depositary Shares
AMYT
| $5.7M | 3.48% |
+402,556
| New | +$5.25M |
|
|
DRNA
6
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $5.01M | 3.06% |
+227,388
| New | +$5.01M |
|
7
Arvinas
ARVN
$534M
| $4.67M | 2.85% |
+55,000
| New | +$1.9M |
|
8
Larimar Therapeutics
LRMR
$379M
| $4.65M | 2.84% |
+217,203
| New | +$4.35M |
|
9
Immunovant
IMVT
$7.89B
| $4.62M | 2.82% |
+100,000
| New | +$4.62M |
|
|
MRTX
10
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $4.39M | 2.68% |
+20,000
| New | +$4.32M |
|
11
Curis
CRIS
$8.67M
| $4.34M | 2.65% |
+1,325
| New | +$1.59M |
|
12
Halozyme
HALO
$8.9B
| $4.27M | 2.61% |
+100,000
| New | +$3.59M |
|
|
TCRR
13
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
| $4.21M | 2.57% |
+136,000
| New | +$3.44M |
|
14
Sutro Biopharma
STRO
$436M
| $4.02M | 2.45% |
+18,500
| New | +$3.06M |
|
|
IMGN
15
DELISTED
Immunogen Inc
IMGN
| $3.87M | 2.36% |
+600,000
| New | +$3.5M |
|
|
EPIX
16
DELISTED
ESSA Pharma
EPIX
| $3.85M | 2.35% |
+322,917
| New | +$2.27M |
|
17
Cellectar Biosciences
CLRB
$21.1M
| $3.69M | 2.25% |
+5,909
| New | +$2.72M |
|
|
CCXI
18
DELISTED
ChemoCentryx, Inc.
CCXI
| $3.33M | 2.03% |
+53,766
| New | +$3.08M |
|
19
Kura Oncology
KURA
$1,000M
| $2.94M | 1.79% |
+90,000
| New | +$3.16M |
|
20
Ascendis Pharma A/S
ASND
$17.4B
| $2.93M | 1.79% |
+17,556
| New | +$2.9M |
|
|
JNCE
21
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $2.85M | 1.74% |
+406,665
| New | +$3.17M |
|
22
Evogene
EVGN
$5.82M
| $2.82M | 1.72% |
+60,000
| New | +$2.12M |
|
23
Cogent Biosciences
COGT
$6.56B
| $2.64M | 1.61% |
+235,066
| New | +$2.58M |
|
24
MoonLake Immunotherapeutics
MLTX
$1.64B
| $2.44M | 1.49% |
+215,071
| New | +$2.28M |
|
25
Guardant Health
GH
$21.8B
| $2.43M | 1.48% |
+18,825
| New | +$2.17M |
|
Similar funds
BOTOTLSJU
EFG
LA
EPIMS
CFP
USAA
OMC
AIA